drugset / Trial / NCT01527734
Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers
RandomizedCrossoverQuadruple-blindScreening
Summary
The study design is a randomized, double-blind, placebo-controlled, parallel-group, dose comparison with a open-label, crossover, formulation comparison.
Timeline
- Start
- 2011-12
- Primary completion
- 2012-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tetrodotoxin | Small molecule | 15 ug | Subcutaneous |
| Subject | Tetrodotoxin | Small molecule | 30 ug | Subcutaneous |
Indications
No indication recorded.